JP2002518502A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002518502A5 JP2002518502A5 JP2000555901A JP2000555901A JP2002518502A5 JP 2002518502 A5 JP2002518502 A5 JP 2002518502A5 JP 2000555901 A JP2000555901 A JP 2000555901A JP 2000555901 A JP2000555901 A JP 2000555901A JP 2002518502 A5 JP2002518502 A5 JP 2002518502A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- tumor
- wavelength
- light
- exposing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 12
- 206010028980 Neoplasm Diseases 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/102,394 US5952366A (en) | 1996-03-08 | 1998-06-22 | Alkyl ether analogs of chlorins having an N-substituted imide ring |
| US09/102,394 | 1998-06-22 | ||
| PCT/US1999/004924 WO1999067249A1 (en) | 1998-06-22 | 1999-03-05 | Alkyl ether analogs of chlorins having an n-substituted imide ring |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002518502A JP2002518502A (ja) | 2002-06-25 |
| JP2002518502A5 true JP2002518502A5 (enExample) | 2006-03-02 |
Family
ID=22289615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000555901A Pending JP2002518502A (ja) | 1998-06-22 | 1999-03-05 | Ｎ−置換イミド環を有するクロリンのアルキルエーテル類似体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5952366A (enExample) |
| EP (1) | EP1090006A4 (enExample) |
| JP (1) | JP2002518502A (enExample) |
| CA (1) | CA2335514C (enExample) |
| WO (1) | WO1999067249A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE39094E1 (en) | 1988-07-20 | 2006-05-09 | Health Research, Inc. | Pyropheophorbides and their use in photodynamic therapy |
| USRE38994E1 (en) | 1988-07-20 | 2006-02-28 | Health Research, Inc. | Pyropheophorbides conjugates and their use in photodynamic therapy |
| JP2002534218A (ja) | 1999-01-15 | 2002-10-15 | ライト サイエンシーズ コーポレイション | 非侵襲性の脈管療法 |
| US6454789B1 (en) | 1999-01-15 | 2002-09-24 | Light Science Corporation | Patient portable device for photodynamic therapy |
| US6602274B1 (en) | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
| EP1131100B1 (en) * | 1999-01-15 | 2003-03-12 | Light Sciences Corporation | Therapeutic compositions for metabolic bone disorders or bone metastases comprising a photosensitizer and a bisphosphonate |
| US20030114434A1 (en) * | 1999-08-31 | 2003-06-19 | James Chen | Extended duration light activated cancer therapy |
| US6534040B2 (en) | 1999-12-23 | 2003-03-18 | Health Research, Inc. | Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
| US7097826B2 (en) | 1999-12-23 | 2006-08-29 | Health Research, Inc. | Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| US7078014B2 (en) * | 1999-12-23 | 2006-07-18 | Health Research, Inc. | Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| EP1267935A2 (en) * | 2000-01-12 | 2003-01-02 | Light Sciences Corporation | Novel treatment for eye disease |
| US6624187B1 (en) * | 2000-06-12 | 2003-09-23 | Health Research, Inc. | Long wave length absorbing bacteriochlorin alkyl ether analogs |
| US6849607B2 (en) * | 2001-05-09 | 2005-02-01 | Health Research, Inc. | Galectin recognized photosensitizers for photodynamic therapy |
| WO2004002476A2 (en) * | 2002-06-27 | 2004-01-08 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| EP1606291A2 (en) * | 2002-07-02 | 2005-12-21 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its dervatives |
| US7057100B2 (en) * | 2003-06-26 | 2006-06-06 | The J.C. Robinson Seed Co. | Inbred corn line W23129 |
| RU2259200C1 (ru) * | 2004-02-16 | 2005-08-27 | Рузиев Рамзес Джауланович | Сенсибилизатор для фотодинамического разрушения клеток злокачественных новообразований и фармацевтическая композиция с его использованием |
| WO2008008215A2 (en) * | 2006-07-10 | 2008-01-17 | Health Research, Inc. | Method for enhancing pdt efficacy using a tyrosine kinase inhibitor |
| US20120034156A1 (en) * | 2010-08-03 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Artificial cells |
| WO2017151836A1 (en) | 2016-03-04 | 2017-09-08 | East Carolina University | J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders |
| WO2018035281A1 (en) | 2016-08-17 | 2018-02-22 | North Carolina State University | Northern-southern route to synthesis of bacteriochlorins |
| WO2018102252A1 (en) | 2016-11-30 | 2018-06-07 | North Carolina State University | Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds |
| EP3675866B1 (en) | 2017-09-01 | 2023-08-02 | East Carolina University | Ex vivo methods for activating immune cells |
| CA3138403A1 (en) | 2019-05-20 | 2020-11-26 | Christopher J. MACNEVIN | Narrow emission dyes, compositions comprising same, and methods for making and using same |
| JP2022532925A (ja) | 2019-05-20 | 2022-07-20 | ニルバナ サイエンシーズ インク． | 発光波長の範囲が狭い発光染料、それを含む組成物及びそれを製造及び使用する方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5002962A (en) * | 1988-07-20 | 1991-03-26 | Health Research, Inc. | Photosensitizing agents |
| US5591847A (en) * | 1994-05-23 | 1997-01-07 | Health Research, Inc. | Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages |
| US5770730A (en) * | 1996-03-08 | 1998-06-23 | Health Research, Inc. | Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer |
-
1998
- 1998-06-22 US US09/102,394 patent/US5952366A/en not_active Expired - Fee Related
-
1999
- 1999-03-05 JP JP2000555901A patent/JP2002518502A/ja active Pending
- 1999-03-05 EP EP99909878A patent/EP1090006A4/en not_active Withdrawn
- 1999-03-05 CA CA002335514A patent/CA2335514C/en not_active Expired - Fee Related
- 1999-03-05 WO PCT/US1999/004924 patent/WO1999067249A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002518502A5 (enExample) | ||
| JP2002508362A5 (ja) | １−置換−１−アミノメチル−シクロアルカン誘導体（＝ガバペンチン類縁体） | |
| JP2002508352A5 (ja) | ４(３)置換−４(３)−アミノメチル−（チオ）ピラン又はピペリジン誘導体（＝ガバペンチン類似体） | |
| JP2002508361A5 (enExample) | ||
| JP2003532731A5 (enExample) | ||
| JP2003531118A5 (enExample) | ||
| JP2002543183A5 (enExample) | ||
| PL328430A1 (en) | Intracolonic administration of nicotine for treating intestinal inflammatory diseases | |
| JP2002527474A5 (ja) | 躁病および双極性障害の治療のための医薬 | |
| DE60018064D1 (de) | Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar) | |
| EP1797878A3 (en) | Benzothiazole derivatives | |
| CO5570109A1 (es) | Compuestos de dihidropirimidina heterociclicos | |
| JP2007503202A5 (enExample) | ||
| JP2001526218A5 (enExample) | ||
| TNSN04167A1 (fr) | Derives de thiazole et d'oxazole qui modulent l'activite de ppar | |
| TNSN04168A1 (fr) | Derives de thiazole et d'oxazole qui modulent l'activite de ppar | |
| JP2006507220A5 (enExample) | ||
| JP2001520998A5 (enExample) | ||
| JP2002510633A5 (enExample) | ||
| EP0285287A3 (en) | 3-benzazepine compounds for use in treating gastrointestinal motility disorders | |
| JP2003522198A5 (enExample) | ||
| JP2004532240A5 (enExample) | ||
| JP2003503449A5 (enExample) | ||
| JP2002527414A5 (enExample) | ||
| JP2002525323A5 (enExample) |